The Netherlands Friday suspended use of the Oxford/AstraZenca vaccine for folks beneath the age of 60, citing concern about an elevated danger of blood clots.
In a assertion, the federal government mentioned there had been 5 studies of thrombosis and abnormally low platelets, which assist blood clot, in ladies aged 25 to 65 (round 400,000 AstraZeneca injections have been given within the Netherlands, based on the identical authorities assertion).
Hugo de Jonge, the outgoing well being minister, mentioned “the essential query is whether or not it considerations complaints after vaccination or as a consequence of vaccination … We should err on the aspect of warning, which is why it’s clever to press the pause button now as a precaution.”
On Tuesday, German Chancellor Angela Merkel and Well being Minister Jens Spahn mentioned the Oxford/AstraZeneca vaccine could be suspended for these beneath 60. “We now have to have the ability to belief the vaccines,” Merkel mentioned.
France has restricted the Oxford/AstraZeneca vaccine to over 55s.
In a report out Thursday, the U.Okay.’s drug security regulator mentioned it had recognized extra circumstances of thrombosis amongst recipients of the Oxford/AstraZeneca vaccine, bringing the whole to 30 — although it mentioned the advantages of the shot nonetheless far outweigh the dangers.
The European Medicines Company has to this point mentioned that the vaccine is protected and suggested nations to proceed utilizing it. Nevertheless, the EMA’s human medicines committee is investigating studies into potential unwanted effects.